North America Neurology Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 8.40 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Neurology Devices Market Analysis
The North American neurology devices market is expected to register a CAGR of 8.4% during the forecast period.
- The COVID-19 pandemic significantly impacted the global healthcare systems, with substantial consequences for COVID-19-infected patients and others, resulting in the cancellation of treatment and surgical procedures to manage and reserve resources; for instance, in September 2021, WHO stated that people who already had neurological conditions were disproportionately affected by COVID-19. In hospitalized COVID-19 patients, chronic neurological conditions were revealed to be independently linked with higher mortality. Routine care interruptions, delayed treatment due to concerns about infectious risks, disruptions in the supply chains for medicines, and the resulting stock-outs had an impact on those with pre-existing neurological problems. The resumed services, treatment, surgical procedures, and increased hospital visits will likely increase the demand for neurology devices.
- The rising aging population and increase in the incidence of neurological disorders, huge investments by private players in neurology devices, and growth in R&D in the field of neuro therapies are expected to drive the market studied in North America. For instance, according to a report published by Alzheimer's Association in March 2022, a vast majority of people who develop Alzheimer's dementia are aged 65 years or older. An estimated 6.5 million Americans aged 65 and older are living with Alzheimer's dementia. This number is assumed to grow to 13.8 million by 2060, barring the development of medical breakthroughs to prevent, slow, or cure Alzheimer's disease. In the United States, nearly 5.3% of people aged 65 to 74 years, 13.8% of people aged 75 to 84 years, and 34.6% of people aged 85 years or older have Alzheimer's dementia.
- In addition, the growing geriatric population and the presence of robust healthcare infrastructure for neurological diagnostics and treatment are also contributing to the growth of the neurology devices market over the forecast period. For instance, the World Population Ageing 2021 report states that more than 46 million adults aged 65 and older live in the United States. By 2050, that number is expected to grow to almost 90 million. Similarly, the Mexican population aged 65 is projected to reach 9.31 million by 2030. Thus, the increasing aging population is more prone to develop neurological disorders, which are expected to increase the demand for various neurology devices for diagnosing and treatment of the conditions, which is expected to fuel the market growth in North America.
- Moreover, the rising company initiatives to develop neurology devices in the region contribute to the market's growth. For instance, in January 2021, the United States FDA granted clearance to ClearMind Biomedical's neuro endoscope, the Axonpen System. This system can illuminate and visualize intracranial tissue and fluids and the controlled tissue and fluid aspiration during surgery. In April 2022, Abbott launched an upgraded version of its digital health app, NeuroSphere myPath. The app's functionality has been enhanced to better assist physicians in monitoring their patients as they utilize Abbott neurostimulation devices to treat their chronic pain. Thus, the North American market is expected to gain traction due to the significant increase in company initiatives to develop neurology devices.
- Therefore, the abovementioned factors are attributed collectively to the studied market growth over the forecast period. However, the high equipment cost, stringent FDA validation, and new device guidelines are expected to hinder market growth over the forecast period.
North America Neurology Devices Market Trends
This section covers the major market trends shaping the North America Neurology Devices Market according to our research experts:
Cerebrospinal Fluid Management Devices is Expected to Witness High Growth over the Forecast Period
Cerebrospinal fluid (CSF) devices drain a buildup of CSF in the brain (hydrocephalus). Cerebrospinal fluid (CSF) devices treat hydrocephalus, a standard medical procedure and life-saving treatment for many patients. These shunt systems drain excess fluid from the brain to another part of the body, where the fluid is absorbed as part of the circulatory process. If left unchecked, CSF imbalance can lead to elevated intracranial pressure (ICP), leading to various complications. CSF shunts can be used to alleviate these problems in patients who suffer from hydrocephalus. According to the Cleveland Clinic April 2022 report, one to two out of every 1,000 newborns are born with hydrocephalus in the United States. Additionally, according to Hydrocephalus Association 2022 report, hydrocephalus affects over 1 million Americans, ranging from infants and older children to young and middle-aged adults and seniors. As the number of patients increases, the shunt systems are used, and so does the segment's growth.
Product launches, approval, and increased focus by several players on their expanding product portfolios in neurosurgery will propel the North American neurology devices market. For instance, in July 2021, Medtronic launched the Percept PC Deep Brain Stimulation (DBS) system. The system integrated with BrainSense technology is made to administer therapeutic stimulation inside and outside the clinic while simultaneously capturing brain signals. The Percept PC device is indicated for individuals with Parkinson's disease, tremors, dystonia, and epilepsy and provides enhanced comfort. An increase in product launches and approval is emerging as a critical trend that is likely to drive the growth of the neurology devices market in North America.
The United States is Expected to Register Significant Growth in the North American Neurology Devices Market
The United States is expected to have a significant share in the neurology devices market owing to the factors such as the rising prevalence of neurological disorders and the rising geriatric population in the country.
The increasing burden of neurological disorders such as Alzheimer's disease, epilepsy, Parkinson's disease, neuromuscular disorders, and others is the key factor driving the market's growth. For instance, according to data from Alzheimers.org, 6.2 million Americans aged 65 and older were thought to have Alzheimer's-related dementia in the United States in 2021. Thus, the rising burden of neurological diseases among the United States population is expected to increase the demand for early diagnosis and treatment, further increasing the demand for neurology devices, thereby propelling market growth. Moreover, as per the 2022 report from Cancer.net, approximately 5,900 brain and other CNS tumors are anticipated to be diagnosed in children ages 0 to 19 in the United States. After leukemia, brain and other CNS tumors are the second most common childhood cancers, accounting for about 26% of cancer in children younger than 15 and 21% in teens ages 15 to 19 in the United States.
In addition, the growing geriatric population and the presence of robust healthcare infrastructure for neurological diagnostics and treatment are also contributing to the growth of the neurology devices market over the forecast period. For instance, according to the March 2021 report of the Alzheimer's Association, approximately 6.2 million people of age 65 years and more are living with Alzheimer's-related dementia in the United States, and it is projected that this number will increase to 13.8 million people by 2060. Thus, the increasing aging population is more prone to develop neurological disorders. This is expected to increase the demand for various neurology devices for diagnosing and treating the conditions, which is expected to fuel market growth.
Thus, the increasing prevalence of neurological disorders and the growing senior population in the United States is expected to augment the market growth over the forecast period.
North America Neurology Devices Industry Overview
The North American neurology devices market is consolidated in nature due to the presence of a few companies operating. The competitive landscape includes an analysis of a few North American companies which hold market shares and are well known, including Abbott Laboratories, B. Braun SE, Boston Scientific Corporation, Medtronic PLC, Stryker, and Nihon Kohden Corporation.
North America Neurology Devices Market Leaders
-
Abbott Laboratories
-
Boston Scientific Corporation
-
Medtronic PLC
-
Stryker
-
B. Braun SE
*Disclaimer: Major Players sorted in no particular order
North America Neurology Devices Market News
- October 2022: Medtronic launched the Neurovascular Co-Lab Platform for accelerating innovation in stroke care and treatment to drive collaboration and connections to help bring neurovascular innovations to life.
- April 2022: Abbott launched an upgraded version of its digital health app, NeuroSphere myPath. The app's functionality has been enhanced so that it may better assist physicians in monitoring their patients as they utilize Abbott neurostimulation devices to treat their chronic pain.
North America Neurology Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Aging Population and Increase in Incidence of Neurological Disorders
- 4.2.2 Huge Investments by Private Players in Neurology Devices
- 4.2.3 Increase in R&D in the Field of Neurotherapies
-
4.3 Market Restraints
- 4.3.1 High Cost of Equipment
- 4.3.2 Stringent FDA Validation and Guidelines for New Devices
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Device
- 5.1.1 Cerebrospinal Fluid Management Devices
- 5.1.2 Interventional Neurology Devices
- 5.1.2.1 Interventional/Surgical Simulators
- 5.1.2.2 Neurothrombectomy Devices
- 5.1.2.3 Carotid Artery Stents
- 5.1.2.4 Embolic Coils
- 5.1.2.5 Support Devices
- 5.1.3 Neurosurgery Devices
- 5.1.3.1 Neuroendoscopes
- 5.1.3.2 Stereotactic Systems
- 5.1.3.3 Aneurysm Clips
- 5.1.3.4 Other Neurosurgery Devices
- 5.1.4 Neurostimulation Devices
- 5.1.4.1 Spinal Cord Stimulation Devices
- 5.1.4.2 Deep Brain Stimulation Devices
- 5.1.4.3 Sacral Nerve Stimulation Devices
- 5.1.4.4 Other Neurostimulation Devices
- 5.1.5 Other Devices
-
5.2 By Geography
- 5.2.1 United States
- 5.2.2 Canada
- 5.2.3 Mexico
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbott Laboratories
- 6.1.2 B. Braun SE
- 6.1.3 Boston Scientific Corporation
- 6.1.4 Johnson and Johnson
- 6.1.5 MicroPort Scientific Corporation
- 6.1.6 Medtronic PLC
- 6.1.7 Nihon Kohden Corporation
- 6.1.8 Penumbra Inc.
- 6.1.9 Smith & Nephew
- 6.1.10 Stryker Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNorth America Neurology Devices Industry Segmentation
As per the scope of the report, neurology devices help diagnose, prevent, and treat various neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, epilepsy, spinal cord injury, and traumatic brain injury. These devices can help restore hearing and sight and provide increased functionality for those with limb loss or congenital limb differences. The North American neurology devices market is segmented by device (cerebrospinal fluid management device, interventional neurology device, neurosurgery device, neurostimulation device, and other devices) and geography (United States, Canada, and Mexico). The market report also covers the estimated market sizes and trends for three different countries across North America. The report offers the value (in USD million) for the above segments.
| By Device | Cerebrospinal Fluid Management Devices | |
| Interventional Neurology Devices | Interventional/Surgical Simulators | |
| Neurothrombectomy Devices | ||
| Carotid Artery Stents | ||
| Embolic Coils | ||
| Support Devices | ||
| Neurosurgery Devices | Neuroendoscopes | |
| Stereotactic Systems | ||
| Aneurysm Clips | ||
| Other Neurosurgery Devices | ||
| Neurostimulation Devices | Spinal Cord Stimulation Devices | |
| Deep Brain Stimulation Devices | ||
| Sacral Nerve Stimulation Devices | ||
| Other Neurostimulation Devices | ||
| Other Devices | ||
| By Geography | United States | |
| Canada | ||
| Mexico |
North America Neurology Devices Market Research FAQs
What is the current North America Neurology Devices Market size?
The North America Neurology Devices Market is projected to register a CAGR of 8.40% during the forecast period (2024-2029)
Who are the key players in North America Neurology Devices Market?
Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Stryker and B. Braun SE are the major companies operating in the North America Neurology Devices Market.
What years does this North America Neurology Devices Market cover?
The report covers the North America Neurology Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Neurology Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
North America Neurology Devices Industry Report
Statistics for the 2024 North America Neurology Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Neurology Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
